Health In Tech (NASDAQ:HIT) Announces Earnings Results, Beats Expectations By $0.01 EPS

Health In Tech (NASDAQ:HIT) announced its quarterly earnings results on Wednesday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.01, Zacks reports. The company had revenue of $8.77 million during the quarter.

Here are the key takeaways from Health In Tech’s conference call:

• Health In Tech reaffirmed full-year 2026 revenue guidance of $45 million to $50 million, implying roughly 35% to 50% year-over-year growth as the company continues to invest in expansion.
• First-quarter revenue was $8.8 million, up about 9% from last year, but adjusted EBITDA turned negative $1.3 million as spending increased on sales, marketing, and product development.
• The company introduced new reporting metrics: contracted revenue of about $22.9 million for the rest of 2026 and platform placed plan value of $82 million in Q1, which management said gives better visibility into future revenue.
• Management is stepping up investment in distribution, carrier partnerships, and AI-enabled technology, including a new AWS-related development effort and a more proactive broker go-to-market strategy.
• The company highlighted strong early interest in its three-year rate stabilization program and said it is on track for market testing later in 2Q into 3Q 2026, with no upfront deposit required from customers.

Health In Tech Stock Up 1.3%

NASDAQ HIT traded up $0.02 during trading hours on Wednesday, hitting $1.54. 148,631 shares of the stock were exchanged, compared to its average volume of 280,551. The company has a market cap of $92.34 million, a price-to-earnings ratio of 77.00 and a beta of 3.67. Health In Tech has a 12-month low of $0.56 and a 12-month high of $4.02. The stock has a 50-day moving average of $1.59 and a 200 day moving average of $1.56.

Analyst Ratings Changes

A number of equities research analysts have recently commented on HIT shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Health In Tech in a report on Thursday, April 2nd. Wall Street Zen cut shares of Health In Tech from a “hold” rating to a “sell” rating in a report on Saturday, April 25th. Finally, Craig Hallum started coverage on shares of Health In Tech in a report on Monday, April 20th. They issued a “buy” rating and a $4.00 target price for the company. Two research analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $3.25.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC raised its holdings in Health In Tech by 307.9% during the fourth quarter. Jane Street Group LLC now owns 50,648 shares of the company’s stock worth $81,000 after purchasing an additional 38,230 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Health In Tech during the third quarter worth about $45,000. Millennium Management LLC purchased a new position in Health In Tech during the third quarter worth about $85,000. State Street Corp raised its holdings in Health In Tech by 195.3% during the fourth quarter. State Street Corp now owns 62,900 shares of the company’s stock worth $100,000 after purchasing an additional 41,600 shares in the last quarter. Finally, XTX Topco Ltd purchased a new position in Health In Tech during the fourth quarter worth about $203,000.

About Health In Tech

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.